Dr Hannah Lingard: Publications

Selective Inhibition of Acetyl-Lysine Effector Domains of the Bromodomain Family in Oncology

Cancer Drug Discovery and Development Springer Nature (2014) 279-298

Authors:

Susanne Müller, Hannah Lingard, Stefan Knapp

RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain

Proceedings of the National Academy of Sciences of the United States of America Proceedings of the National Academy of Sciences 110:49 (2013) 19754-19759

Authors:

Sarah Picaud, Christopher Wells, Ildiko Felletar, Deborah Brotherton, Sarah Martin, Pavel Savitsky, Beatriz Diez-Dacal, Martin Philpott, Chas Bountra, Hannah Lingard, Oleg Fedorov, Susanne Müller, Paul E Brennan, Stefan Knapp, Panagis Filippakopoulos

Nuclear Signaling Pathways and Targeting Transcription in Cancer

Chapter in Nuclear Signaling Pathways and Targeting Transcription in Cancer, Humana Press (2013) 11

Abstract:

In addition, this book will offer a comprehensive basic and clinical science behind the functions of representative core transcriptional factors.

pH‐Dependent Conformational Switching in 2,6‐Benzamidodiphenylacetylenes

Angewandte Chemie International Edition Wiley 50:52 (2011) 12569-12571

Authors:

Ian M Jones, Hannah Lingard, Andrew D Hamilton

Cascade approaches to complex nitrogen-containing frameworks

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 239 (2010)

Authors:

Hannah K Lingard, Sam Thompson, David K Dean, Martin D Smith

51��